Success Story: Accomplished Immunology Researcher from Bangladesh Successfully Secures I-140 NIW Approval
Client’s Testimonial:
"Thank you very much for sharing the great news."
On June 17th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Post-Doctoral Research Associate in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Post-Doctoral Research Associate
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Tennessee
Approval Notice Date: June 17th, 2026
Processing Time: 27 months, 6 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group is pleased to share the approval of an I-140 NIW petition for an immunology researcher from Bangladesh. Prepared under the Dhanasar framework, the petition demonstrated the substantial merit and national importance of the proposed endeavor, the client’s strong positioning to advance it, and the benefit of waiving the job offer and labor certification requirements. At the time of filing, the client was conducting research at a U.S. research institution and held a Ph.D. in preventive veterinary science.
Proposed Endeavor and National Importance
The client’s proposed endeavor focused on elucidating inflammasome activation in infectious diseases to better understand immune responses to diverse pathogens, reveal molecular mechanisms of inflammation, and identify diagnostic markers and therapeutic interventions. The petition explained that the client’s work examines innate immune signaling pathways, inflammation, infectious diseases, and cancer by studying how immune proteins activate and regulate responses to biological threats.
We demonstrated that this work supports national needs because infectious diseases remain a major public health concern in the United States and worldwide. By clarifying how immune responses are activated, overactivated, or suppressed, the client’s research may help support improved diagnosis, therapeutic development, and patient outcomes in infectious disease and immune-response research.
Objective Evidence of Expertise
To show that the client was well-positioned to advance the endeavor, the petition presented objective evidence of scholarly productivity, citation impact, highly ranked publication venues, funded research, and independent scholarly reliance. The client’s record included:
- 8 peer-reviewed journal articles, including 5 first-authored articles
- 1 accepted journal article
86 citations to the client’s published work
- Research support from the National Key Research and Development Program of China, the Gansu Provincial Major Project for Science and Technology Development, the Chinese Academy of Agricultural Science and Technology Innovation Project, and the National Natural Sciences Foundation of China
Demonstrating the Client’s Significance
The petition showed that the client’s significance extended beyond publication numbers. We demonstrated that independent researchers had relied on the client’s work in studies involving various aspects of immune response and infectious disease research. These citations showed that the client’s findings had become useful to other scholars studying host immune responses and infectious disease mechanisms.
We also highlighted that several of the client’s papers were cited at notable rates in Immunology, including 3 papers ranked among the top 10% and 1 paper ranked among the top 20% most-cited articles for their respective publication years. This helped show that the client’s work had attracted meaningful recognition within the field rather than reflecting publication activity alone.
NIW Approval and Outlook
The petition connected the client’s prior research record to the proposed immunology endeavor by emphasizing the client’s experience with innate immune signaling pathways, inflammasome activation, inflammation, infectious diseases, and molecular regulation of immune responses. The case focused on objective evidence of education, publication record, citation impact, funded research, independent scholarly reliance, current research role, and future research plans.
We congratulate the client on this I-140 NIW approval and look forward to the client’s continued contributions to immunology, infectious disease research, and immune-response studies in the United States.